On Tuesday, Hillary Clinton announced her proposal for lowering the cost of prescription drugs at a public forum in Des Moines, Iowa. Ahead of the announcement, Clinton had tweeted a link to The New York Times's investigation of Daraprim—a drug acquired by the startup Turing Pharmaceuticals (whose CEO is best described as bombastic) that saw an overnight price increase of 5,000 percent.
Price gouging like this in the specialty drug market is outrageous. Tomorrow I'll lay out a plan to take it on. -H https://t.co/9Z0Aw7aI6h— Hillary Clinton (@HillaryClinton) September 21, 2015
Clinton’s outrage was echoed across the Internet, with Turing now saying they’re going to roll back the price. (It’s also speculated that Clinton spooked investors, who dropped biotech stocks after her tweet.)
As my colleague Julie Beck reported, Daraprim is only one example of prescription drugs whose prices skyrocket. As Republican presidential candidates campaign on repealing the Affordable Care Act, Clinton and her fellow Democratic candidate Bernie Sanders have been laying out plans to take on health-care affordability. One prong in those plans is to take on pharmaceutical companies—Americans continue to pay some of the highest prices in the world for prescription drugs.